Clinical Trial Update: Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing olanzapine to an active comparator in depression associated with schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• olanzapine (olanzapine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Depression, Schizophrenia | Phase 4 | Status: COMPLETED